Literature DB >> 22191553

Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder.

David J Kupfer1, Jules Angst, Michael Berk, Faith Dickerson, Sophia Frangou, Ellen Frank, Benjamin I Goldstein, Allison Harvey, Fouzia Laghrissi-Thode, Marion Leboyer, Michael J Ostacher, Etienne Sibille, Stephen M Strakowski, Trisha Suppes, Mauricio Tohen, Robert H Yolken, L Trevor Young, Carlos A Zarate.   

Abstract

Recently, the 9(th) International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders-both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD).
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191553     DOI: 10.1111/j.1749-6632.2011.06336.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  [Are bipolar disorders much more common than previously assumed? Against].

Authors:  E Severus
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

2.  Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care.

Authors:  Jia Hu; Rodrigo Mansur; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2014-04-17

3.  A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies.

Authors:  Lun-Ching Chang; Stephane Jamain; Chien-Wei Lin; Dan Rujescu; George C Tseng; Etienne Sibille
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

4.  Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder.

Authors:  A Versace; A C Andreazza; L T Young; J C Fournier; J R C Almeida; R S Stiffler; J C Lockovich; H A Aslam; M H Pollock; H Park; V L Nimgaonkar; D J Kupfer; M L Phillips
Journal:  Mol Psychiatry       Date:  2013-01-29       Impact factor: 15.992

5.  An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors.

Authors:  R N Arey; J F Enwright; S M Spencer; E Falcon; A R Ozburn; S Ghose; C Tamminga; C A McClung
Journal:  Mol Psychiatry       Date:  2013-02-12       Impact factor: 15.992

6.  Functional Implications of the CLOCK 3111T/C Single-Nucleotide Polymorphism.

Authors:  Angela R Ozburn; Kush Purohit; Puja K Parekh; Gabrielle N Kaplan; Edgardo Falcon; Shibani Mukherjee; Hannah M Cates; Colleen A McClung
Journal:  Front Psychiatry       Date:  2016-04-21       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.